Hollowood Christopher John

Type: individual

Citizenship: British

Age: 52

Manages

Investment professional
Ceo
Ceo
Investor
Investment professional

Last changes

  1. Purespring Therapeutics Limited
    Confirmation statement made on 2026-03-31 with updates
  2. Purespring Therapeutics Limited
    Change of details for Syncona Limited as a person with significant control on 2025-10-31
  3. Purespring Therapeutics Limited
    Change of details for Syncona Limited as a person with significant control on 2024-10-08
  4. Beacon Therapeutics Holdings Limited
    Statement of capital following an allotment of shares on 2026-01-19
  5. Beacon Therapeutics Holdings Limited
    legacy

Co-directors of Hollowood Christopher John

Walsh Colin
Macdonald James Jay
Ahmad Haseeb
Butler Katherine Elizabeth
Franken Arthur Lodewijk
Galbraith Kenneth Harry
Bhaman Maina
Boorsma Marco
Hallen Sonia
Baldo Lance

FAQ about Hollowood Christopher John

Looking for leads in the UK?

Book a demo—see how CorpSignals can help you find UK leads.

Book a demo Learn more

GDPR compliance

The data on this page is derived from the public records of Companies House and is processed by fully automated ML and AI algorithms. Please note that this data may contain errors. It is provided on an "as is" basis without any guarantees regarding completeness, accuracy, usefulness, or timeliness.

As per the guidance on personal data on the Companies House register, this personal data is exempt from certain data protection requirements. This is because the law mandates the public availability of this information. Other organisations, including ours, have the legal right to replicate information from the public register. For inquiries or concerns regarding data protection and privacy, please contact us at gdpr@corpsignals.com.